Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Zaid Baha

Psychiatry Flint, MI Doctor of Osteopathy

NPI 1447604608 CMS profile 7216361

420 W 5Th Ave, Flint, MI 48503

Open in the dashboard

General payments

$13,583

131 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Zaid Baha of Flint, MI is reported in the CMS Open Payments database as having received $13,583 across 131 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,013 36
2024 General $4,395 42
2023 General $846 44
2022 General $60 3
2019 General $269 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Zaid Baha
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Zaid Baha were reported at $8,013. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Zaid Baha Psychiatry median Middle half National median
2019 $269 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $60 $153 $50–$590 $149
2023 $846 $170 $56–$651 $160
2024 $4,395 $179 $57–$673 $164
2025 $8,013 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $6,453 31 payments
  2. Teva Pharmaceuticals USA, Inc. $4,947 11 payments
  3. Alkermes, Inc. $552 27 payments
  4. E.R. Squibb & Sons, L.L.C. $347 11 payments
  5. Otsuka America Pharmaceutical, Inc. $313 13 payments
  6. Janssen Pharmaceuticals, Inc $299 11 payments
  7. Indivior Inc. $270 13 payments
  8. Neurocrine Biosciences, Inc. $144 6 payments
  9. Avanir Pharmaceuticals, Inc. $131 2 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $40 1 payment
  11. Other $87 5 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $10,570 5 payments
  2. Food and Beverage $2,902 125 payments
  3. Education $111 1 payment
Products named General payments · program years 2019–2025
  1. UZEDY $4,730 5 payments
  2. VRAYLAR Neuroscience $3,974 29 payments
  3. VRAYLAR Neuroscience $2,479 2 payments
  4. LYBALVI $526 26 payments
  5. ARISTADA Cns $526 26 payments
  6. ARISTADA Cns $526 26 payments
  7. ARISTADA Cns $502 25 payments
  8. ARISTADA Cns $502 25 payments
  9. PERSERIS $242 12 payments
  10. COBENFY $220 9 payments
  11. Other $1,277 51 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

176

Median for Psychiatry: 574

Drug cost

$1,399

Median for Psychiatry: $27,624

Branded share of claims

0%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Quetiapine Fumarate Generic 21 $343
Olanzapine Generic 12 $254
Prazosin Hcl Generic 16 $194
Trazodone Hcl Generic 22 $124
Lorazepam Generic 25 $115
Lamotrigine Generic 32 $113
Hydroxyzine Pamoate Generic 11 $101
Clonidine Hcl Generic 26 $87
Lithium Carbonate Generic 11 $68

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$1,534

Medicare's payments for the services billed

Medicare patients

16

Average age 47

Services billed

21

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Heart failure 0%
Ischemic heart disease 0%
Cancer 0%
Osteoporosis 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 15 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
VRAYLAR
  • AbbVie, Inc. $3,758
$3,758 — —
ARISTADA
  • Alkermes, Inc. $104
$104 — —
SPRAVATO
  • Janssen Pharmaceuticals, Inc $88
$88 — —
PERSERIS
  • Indivior Inc. $49
$49 — —
UZEDY
  • Teva Pharmaceuticals USA, Inc. $46
$46 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 15 in the dashboard with a free account

Records

131 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record